Pricing Log in Create free account
Friday 6 November 2026 Export TFX’s income statement to Excel — free account

Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.

Revenue
+28.9%
EPS
−17.3%
Free cash flow
+220.1%
Total debt
+47.7%

Quarter to June 2026, against a year earlier

152.16 2.29 +1.53%
Market cap
$6.5B
P/E
0.0×
Fwd P/E
37.4×
Dividend yield
0.89%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Teleflex Incorporated (TFX) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Teleflex Incorporated (TFX) trades at a EV/EBITDA of 35.7×. Over the past ten years it has ranged from 12.0× (October 2023) to 48.7× (September 2024); the current reading is higher than 90% of that period. That is above the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 25.6× (29.36%)
FY2024 36.3× 10.20%
FY2023 32.9× 84.02%
FY2022 17.9× (16.92%)
FY2021 21.5× (33.61%)
FY2020 32.4× 9.17%
FY2019 29.7× 17.08%
FY2018 25.4× 1.01%
FY2017 25.1× 52.55%
FY2016 16.5× 17.50%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 31.3× 7.59%
Mar 2026 29.1× 13.68%
Dec 2025 25.6× (41.01%)
Sep 2025 43.4× 67.00%
42 more quarters

Against its own ten years

Low 12.0× High 48.7×
Ten-year median 25.1×
Current reading's percentile 90

EV/EBITDA against peers

Company EV/EBITDA
PLSE Pulse Biosciences, Inc compare n/m
MMED MiniMed Group, Inc. compare n/m
NVST Envista Holdings Corporation compare 10.3×
ATR AptarGroup, Inc. compare 13.2×
BLCO Bausch + Lomb Corporation compare 14.6×
AVTR Avantor, Inc. compare 14.7×
MMSI Merit Medical Systems, Inc. compare 15.5×
ICUI ICU Medical, Inc. compare 16.0×
TFX Teleflex Incorporated 35.7×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on TFX